Survival Analysis in R
Overall survival from the date of progression.
Oncotarget | Clofarabine/busulfan-based reduced intensity conditioning regimens... | Oncotarget
Chapter 20 Survival Analysis | Econometrics for Business Analytics
Full article: Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice | European Journal of Nuclear Medicine and Molecular Imaging
Differences in survival times between clusters Survival times with... | Download Scientific Diagram
Survival Analysis in R
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Survival (time to event) data: median survival times | The BMJ
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study - The Lancet Public Health
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma | Radiation Oncology | Full Text
Overall survival in days from initial diagnosis | Download Scientific Diagram
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
27 Survival analysis | The Epidemiologist R Handbook
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology
Overall survival curve for the “all taxa” data set (Kaplan-Meier estimate and corresponding 95% confidence intervals; N = 4447; the length of time axis is limited to a maximum of 15 days).
27 Survival analysis | The Epidemiologist R Handbook
Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia
A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram
